GP ILA 1: Broken Heart Flashcards
HTN, MI, CCF, CKD
Heart failure is a clinical syndrome that requires what 3 things?
Typical symptoms, typical signs and objective evidence of structural/functional abnormality
HF
a) Typical symptoms: (i) LFH x4, (ii) RHF x2, (iii) General x3
b) What is liver cirrhosis caused by RHF called?
c) HF caused by lung disease is called…? Give a drug used to treat pulmonary hypertension.
(i) LHF - SOBOE, PND, orthopnoea, pink frothy sputum; (ii) RHF - ankle swelling, abdominal distention;
(iii) General - fatigue, weight loss, nausea
b) Cardiac cirrhosis
c) Cor pulmonale. Sildenafil
HF
b) Typical signs: (i) LHF x3, (ii) RHF x2, (iii) General x3
Think observation, palpation, percussion, auscultation
(i) LHF - pulmonary oedema (bilateral basal end-insp crackles +/- wheeze), pleural effusion (dullness to percussion, decreased vocal resonance/tactile fremitus, pleural rub), cardiomegaly;
(ii) RHF - raised JVP, hepatomegaly, ascites
(iii) General - low BP, tachycardia, reduced pulse pressure, gallop rhythm (S3)
HF
c) Objective evidence: (i) O/E x2, (ii) Bloods x2, (iii) Imaging x2
(i) Cardiomegaly, S3
(ii) BNP, NT-proBNP
(iii) CXR (ABCDE), Echo (EF < 40%)
Systolic (LVSD) vs Diastolic (HFPEF):
a) EF cutoff for LVSD
b) Cause of HFPEF
a) <40%
b) Mitral stenosis (impaired filling); ASD/VSD
High-output cardiac failure:
a) 2 features
b) 4 causes
a) Primary abnormality not cardiac
b) Anaemia, pregnancy, hyperthyroid, Paget’s, AVMs
Aetiology (low-output HF):
a) 2 most common
b) 3 valvular (preload/afterload)
c) 2 other cardiac disease types
d) Drug-induced: (i) 2 prescription, (ii) 2 recreational
e) 5 endocrine
f) 2 nutritional
g) 2 infective
h) 2 infiltrative
a) HTN, MI
b) AS (afterload), AR/MR (preload)
c) Arrhythmias (e.g. AF), cardiomyopathies (DCM, HCM)
d) (i) ABCDE: Beta-blockers, Ca2+, (ii) Cocaine, alcohol
e) Hypo/hyperthyroid, Cushing, Phaeo, Acromegaly, DM
f) Thiamine
g) HIV, Chagas’
h) Sarcoid, amyloid, haemochromatosis
HF Investigations:
a) If previous MI
b) If no previous MI - 2 main
c) Other bloods
d) CXR - 5 signs
a) 2/52 echo - if normal, measure BNP. If echo and BNP normal unlikely to be HF. If normal echo and raised BNP - HFPEF
b) BNP first; also ECG (98% specific)
c) FBC, U&Es, fasting lipids, glucose, TFTs, cardiac enzymes if acute
d) Alveolar oedema (fluid in fissures), kerley B lines, cardiomegaly (CT ratio >50%), upper lobe diversion, pleural effusions
BNP/ NT-proBNP:
a) A measure of…?
b) If levels are high (BNP >400pg/ml or NT-proBNP level >2,000 ng/L) - management?
c) If levels are raised (BNP 100 - 400 or NT-proBNP 400 - 2000) - management?
d) If levels are normal (BNP <100 or NT-proBNP <400) - management?
a) Myocardial stress
b) 2 week echo
c) 6 week echo
d) Unlikely to be HF
NYHA classification (stages 1-4)
Stage 1: asymptomatic on ordinary physical activity
Stage 2: some symptoms on ordinary physical activity
Stage 3: less than ordinary physical activity leads to symptoms
Stage 4: inability to carry out any activity without symptoms
HF: 3 indications for urgent 2-week cardiology and echo referral
BNP >400, severe symptoms, pregnant, previous MI
HF Management:
a) 5 lifestyle
b) Referral to …?
c) 4 drug classes to treat HF (1 symptomatic)
d) 2 to reduce CV mortality
e) 1 other drug to use if not fully managed by BBs
f) Drugs to avoid in heart failure (3)
a) Nutritional - wt loss if fat, appropriate stable weight if cachectic, alcohol, smoking, low salt diet, exercise
b) Community HF nurse
c) Loop diuretics, ACE, BBs, aldosterone antagonist
d) Statins, aspirin
e) Ivabradine - acts on If channel
f) Non-dihydropyridines (verapamil, diltiazem), lithium, fleicanide, TCAs
ACE inhibitors
a) MoA in HF
b) CIs - give 3
c) Prior to treatment, and at 1, 3 and 6 months (then every 6m) - what blood tests?
d) Alternative if not tolerated
a) Improves LV function
b) history of angio-oedema, bilateral renal artery stenosis, hyperkalaemia (>5 mmol/L), severe renal impairment (serum creatinine >220 μmol/L) and severe aortic stenosis.
c) U&Es and creatinine
d) ARB
Beta-blockers
a) MoA in HF
b) CIs - give 4
c) Monitor what two things with each increase in dose
a) Greater diastolic time
b) Asthma, second- or third-degree heart block, sick sinus syndrome (without pacemaker) and sinus bradycardia (<50 beats per minute (bpm)), Raynaud’s
c) HR and BP
Diuretics
a) 2 commonly used in HF
b) 2 risks of excessive diuresis
c) 2 commonly used in HTN - types
a) furosemide, bumetanide
b) hypotension, renal failure
c) Chlortalidone, indapamide